Announcements Trials
Browse Landscape

Phase

Phase 2 30Phase 1/2 9Phase NA 8Phase EARLY_PHASE1 3Phase 3 3Phase 1 3Phase 4 1

Status

Unknown 3

Sponsor Class

INDUSTRY 4OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Breast Neoplasms 552Colorectal Neoplasms 246Neoplasms 232Prostatic Neoplasms 221Carcinoma, Non-Small-Cell Lung 196Stomach Neoplasms 153Leukemia, Myeloid, Acute 149Carcinoma, Hepatocellular 147Lung Neoplasms 137Rectal Neoplasms 135Multiple Myeloma 133Nasopharyngeal Carcinoma 112Colonic Neoplasms 106Neoplasm Metastasis 100Precursor Cell Lymphoblastic Leukemia-Lymphoma 86Lymphoma 85Uterine Cervical Neoplasms 83Pancreatic Neoplasms 82Lymphoma, Large B-Cell, Diffuse 79Ovarian Neoplasms 78Leukemia 78Head and Neck Neoplasms 77Esophageal Neoplasms 74Lymphoma, Follicular 72Brain Neoplasms 70Squamous Cell Carcinoma of Head and Neck 65Recurrence 64Leukemia, Lymphocytic, Chronic, B-Cell 59Lymphoma, Non-Hodgkin 58Pain 56

Interventions

Bevacizumab 2XELOX 1Panitumumab 1Irinotecan 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × OTHER × Colorectal Cancer Metastatic × Clear all
NCT01910610 2024-03-12

STRATEGIC-1

GERCOR - Multidisciplinary Oncology Cooperative Group

Phase 3 Unknown
464 enrolled
Gastrointestinal

Colorectal Cancer Metastatic

NCT02149784 2017-04-27

Effectiveness Study of Resection of Primary Tumor in Stage IV Colorectal Cancer Patients

Sun Yat-sen University

Phase 3 Unknown
480 enrolled
Gastrointestinal

Colorectal Cancer Metastatic

NCT01249638 2011-03-14

Cap+Bev vs Cap+Iri+Bev 1st-line Therapy in mCRC

Ludwig-Maximilians - University of Munich

Phase 3 Unknown
516 enrolled
Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡